Blockade of Tumor Necrosis Factor-Alpha: A Role for Adalimumab in Neovascular Age-Related Macular Degeneration Refractory to Anti-Angiogenesis Therapy

Blockade of Tumor Necrosis Factor-Alpha: A Role for Adalimumab in Neovascular Age-Related Macular Degeneration Refractory to Anti-Angiogenesis Therapy

Aims: To report a case of wet age-related macular degeneration (wet-AMD) refractory to intravitreal anti-vascular endothelial growth factor (anti-VEGF) therapy in a patient who showed visual and anatomical improvement and stabilization after starting a subcutaneous treatment course with adalimumab,...

Full description

Bibliographic Details
Main Authors: Beatriz Fernández-Vega, Álvaro Fernández-Vega, Carlos Mario Rangel, Javier Nicieza, Eva Villota-Deleu, José A. Vega, Ronald M. Sanchez-Avila
Format: Article
Language:English
Published: Karger Publishers 2016-03-01
Series:Case Reports in Ophthalmology
Subjects:
Anti-vascular endothelial growth factor
Tumor necrosis factor-alpha inhibitors
Wet age-related macular degeneration
Online Access:http://www.karger.com/Article/FullText/445102

Internet

http://www.karger.com/Article/FullText/445102

Similar Items